Edward M. Bahnson, PhD

Dr. Edward Moreira Bahnson joined the Dept. of Cell Biology & Physiology, and the Center for Nanotechnology in Drug Delivery as a tenure-track Assistant Professor in 2017. Dr. Bahnson’s research program focuses on the study of arterial disease, and developing new therapies to treat cardiovascular disease. He aims to understand the difference in plaque progression, and restenosis rates when there are changes in the redox environment of the vascular wall, with the goal of developing redox-based targeted therapies for the vasculature.

Dr. Bahnson is originally from Montevideo, Uruguay, the second most southern capital in the world. Dr. Bahnson holds a B.Sc. in Biochemistry from the University of Uruguay, and moved to the US to pursue his doctorate. He received his Ph.D. in Biomedical Sciences working with Drs. Nicola Brasch (Kent State University), June Yun (NEOMED), and Donald Jacobsen (Cleveland Clinic). His dissertation, entitled “Vascular Biochemistry of Vitamin B12,” explored the non-coenzyme effects of B12 derivatives on vascular redox homeostasis. For his postdoctoral training, he joined the Simpson Querrey Institute and the Division of Vascular Surgery at Northwestern University. He focused on the prevention of restenosis after vascular interventions using local and targeted redox interventions.

On a personal note Dr. Bahnson enjoys singing (he has been a part of various choruses over the years), and dancing tango. He also enjoys cooking and baking, and going for a walk with his husband Matthew, their twin daughters Tori and Bella, and their dog Wellington.   Dr. Bahnson’s CV